ACE2 and COVID-19: K18-hACE2 mice express human ACE2 driven by a cytokeratin promotor in epithelia, including airway epithelial cells where SARS-2 infections often start, and they recapitulate severe COVID-19 upon infection with SARS-2 (41–43).